Crawford Fund Management, LLC Axonics, Inc. Transaction History
Crawford Fund Management, LLC
- $577 Billion
- Q4 2024
A detailed history of Crawford Fund Management, LLC transactions in Axonics, Inc. stock. As of the latest transaction made, Crawford Fund Management, LLC holds 10,000 shares of AXNX stock, worth $709,800. This represents 0.12% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$709,800% of portfolio
0.12%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding AXNX
# of Institutions
46Shares Held
10.1MCall Options Held
5.2KPut Options Held
58.3K-
Black Rock Inc. New York, NY4.34MShares$308 Million0.01% of portfolio
-
Putnam Investments LLC Boston, MA239KShares$17 Million0.02% of portfolio
-
Segantii Capital Management LTD165KShares$11.7 Million1.41% of portfolio
-
Credit Suisse Ag Zurich, V899.6KShares$7.07 Million0.01% of portfolio
-
Eisler Capital (Uk) Ltd. London, X098.5KShares$6.99 Million0.03% of portfolio
About Axonics, Inc.
- Ticker AXNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 49,123,600
- Market Cap $3.49B
- Description
- Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...